Stock Markets April 8, 2026

Arxis launches IPO, offering 37.7 million Class A shares at $25 to $28 apiece

Connecticut-based supplier of mission-critical components files to list on Nasdaq Global Select under ticker ARXS

By Ajmal Hussain
Arxis launches IPO, offering 37.7 million Class A shares at $25 to $28 apiece

Arxis Inc. has filed to offer 37,735,849 shares of Class A common stock with an intended price range of $25.00 to $28.00 per share and plans to list on the Nasdaq Global Select Market under the ticker ARXS. The company, a portfolio business of Arcline Investment Management, makes electronic and mechanical components for aerospace, defense, medical technology and industrial customers. The offering is proceeding under a registration statement that is not yet effective and remains subject to market conditions.

Key Points

  • Arxis is offering 37,735,849 Class A shares with an indicated price range of $25.00 to $28.00 per share and intends to list on the Nasdaq Global Select Market under the ticker ARXS.
  • The company is a portfolio business of Arcline Investment Management and designs and manufactures electronic and mechanical components for aerospace, defense, medical technology and industrial markets.
  • A broad underwriting syndicate is in place - led by Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies - with multiple joint and book-running managers participating, reflecting capital markets activity in the financial services sector.

Arxis Inc. has initiated an initial public offering to sell 37,735,849 shares of its Class A common stock, targeting a price between $25.00 and $28.00 per share, the company disclosed in its filing.

The shares are expected to trade on the Nasdaq Global Select Market under the symbol "ARXS." Arxis is identified in the filing as a portfolio company of Arcline Investment Management and is described as a designer and manufacturer of electronic and mechanical components that serve aerospace, defense, medical technology and industrial end markets.

Underwriting syndicate and roles

Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies have been named as lead joint book-running managers for the proposed offering. Citigroup and RBC Capital Markets are listed as joint book-running managers. Additional book-running managers are Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co and Wolfe | Nomura Alliance. Citizens Capital Markets is serving as co-manager.

Regulatory and timing caveats

The company has submitted a registration statement to the Securities and Exchange Commission, but the filing has not been declared effective. The filing explicitly notes that the offering is subject to market conditions and there is no assurance regarding when or whether the offering will be completed or what the final terms might be.

Business focus and operations

Arxis operates out of Bloomfield, Connecticut. The company focuses on components that the filing terms as mission-critical - parts engineered to meet complex performance requirements for customers across a set of specialized markets, including aerospace, defense, medical technology and industrial applications.


The filing provides the framework for the offering and identifies the firms handling distribution and underwriting. Beyond the registration filing and the list of managing banks, the company described its core markets and manufacturing focus but did not set a definitive timetable for the transaction.

Risks

  • The registration statement filed with the Securities and Exchange Commission has not become effective, which means the offering cannot proceed until the filing is declared effective.
  • The offering is subject to market conditions, and there is no assurance regarding the timing of completion or the final terms of the deal.
  • Uncertainty remains around the final pricing and the transaction timetable, as the company has only provided an expected price range and has not set a definitive schedule.

More from Stock Markets

RBC Identifies NEXT and Inditex as Long-Term Winners as Consumer Demand Softens Apr 8, 2026 Rocket Lab Shares Climb After Completion of ATM Equity Program Apr 8, 2026 Insider Moves Spotlight Biotech, Food and Mining-Linked Stocks Amid Mixed Valuation Signals Apr 8, 2026 Markets Rally After Iran Ceasefire; AI-Selected Stocks Lead Premarket Gains Apr 8, 2026 Exyn Technologies Seeks Nasdaq Listing with Share-and-Warrant Units Apr 8, 2026